The Highly Potent Active Pharmaceutical Ingredients Summit offers only the highest-profile of industry speakers presenting keynote topics, taking the experience to an all-new level.
This event will provide you with access to other industry leaders and an environment to discuss process innovation, technology, and safety perspectives for both highly potent active pharmaceutical ingredient (HPAPI) manufacturers and outsourcers. We look forward to inspiring you in Italy!Read more
This event provides its participants access to other industry leaders and an environment to discuss process innovation and technology and safety perspectives for both highly potent active pharmaceutical ingredient (HPAPI) manufacturers and outsourcers.
This Summit will focus on current market trends for HPAPI, including process development and scale-up, cost-effective production, containment innovations and best manufacturing practices as well as regulatory updates.
We are delighted to give you this opportunity to participate at this Summit. We look forward to welcoming you in Milan in February!
Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Fellows and Investigators specialising in:
To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.
Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has worked globally and held senior positions in potent biopharmaceutical occupational health and safety global environmental consulting, board level positions in a biotechnology company and also been involved in corporate environmental management. Justin has worked on multiple ADC projects and specialises in technically complex and strategic projects, including unique experiences in managing sensitive highly potent and toxic biopharmaceutical compound matters.
Richard Denk has studied mechanical engineering and did an examination on experts of GMP, qualification and validation, pharmaceutical auditing, pharmaceutical engineering and quality control at the Albstadt-Sigmaringen University of Applied Sciences in Germany. Richard works at SKAN AG, headquartered in Allschwil, as the head of sales containment. Eight years ago he founded the expert containment group of the ISPE D/A/CH, and in 2015 they published the Containment Manual. Richard has spent nearly 20 years with the production of highly active and highly hazardous substances and has developed the containment pyramid.
Martin Axon is principal occupational hygienist for SafeBridge Europe and is a chartered fellow of the faculty of occupational hygiene. He has degrees in industrial chemistry and environmental pollution science. He has over 25 years of experience working in the pharmaceutical industry in the UK and internationally, where, as an occupational hygienist for primary and secondary sites, he provided support for potent pharmaceutical product manufacture. During mid-career, he was course director for a postgraduate programme in occupational hygiene, health and safety, at London South Bank University. Martin joined SafeBridge in 2005. His current role includes managing SafeBridge’s services in Europe and advising clients on the safe handling of potent pharmaceutical compounds in a range of environments, from laboratory scale through to secondary manufacture.
Oct 2, 2019
5th Annual Highly Potent Active Pharmaceutical Ingredients Summit